Effectiveness of the Myofascial Therapy in the Hemophilic Arthropathy of Ankle

September 26, 2017 updated by: Real Fundación Victoria Eugenia

Randomized Clinical Study on the Effectiveness of the Myofascial Therapy in the Treatment of the Hemophilic Arthropathy of Ankle

Randomized clinical trial to assess the efficacy of a treatment protocol applied fascial therapy in patients with hemophilic arthropathy ankle, oriented to know and describe the observed differences on the dependent variables: range of motion, pain and physical condition.

At the same time, the study will determine whether there are adverse effects or bleeding complications as a result of applied physiotherapy treatment.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

65

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Patients diagnosed with hemophilia A and B
  • Adults patients
  • Patients with hemophilic arthropathy of ankle diagnosed
  • Patients in prophylactic treatment regimen or on demand treatment with concentrates of FVIII/FIX.

Exclusion Criteria:

  • Patients without ambulation
  • Patients diagnosed with other congenital coagulopathy (eg, Von Willebrand disease)
  • Patients who have developed antibodies to FVIII / FIX (inhibitors)
  • Patients with neurological or cognitive impairments that prevent understanding of questionnaires and test physical
  • Patients that have not signed the informed consent document.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Experimental group

Patients included in this group will receive treatment over a period of three weeks, receiving 3 physiotherapy sessions lasting approximately 30 minutes each.

The treatment program includes 8 maneuvers that must be administered bilaterally: maneuver longitudinal sliding on the fascial surface plant, maneuver induction of the plantar fascia, maneuver longitudinal surface sliding on the anterolateral compartment of the leg, induction maneuver ankle anterior compartment, maneuver pressure and sliding on the posterior region of the leg, technical release of the popliteal fascia, maneuver induction sural triceps, and lower extremity telescopic technique.

Physiotherapy by techniques myofascial therapy, in patients with ankle hemophilic arthropathy
NO_INTERVENTION: Control group
Patients included in this group will not receive any physiotherapy treatment. However, will be evaluated under the same conditions that patients in the experimental group (pretreatment evaluation, post-treatment and follow-up).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline bleeding frequency after treatment and at 5 months
Time Frame: Screening visit, within the first seven days after treatment and after five months follow-up visit
Evaluation of the frequency of muscle and joint bleeds through registration. The frequency of bleeding of the ankle joint is measured with a registry given to patients at the beginning of the study.
Screening visit, within the first seven days after treatment and after five months follow-up visit
Change from baseline joint pain of ankle after treatment and at 5 months
Time Frame: Screening visit, within the first seven days after treatment and after five months follow-up visit
Change from joint pain of ankle during treatment and follow-up period at 5 months. The perception of ankle pain will be measured using visual analog scale (scale 0-10).
Screening visit, within the first seven days after treatment and after five months follow-up visit
Change from baseline joint function after treatment and at 5 months
Time Frame: Screening visit, within the first seven days after treatment and after five months follow-up visit
Change from joint health during treatment and follow-up period at 5 months. Measurement instrument: Haemophilia Joint Health Score (scale 0-20).
Screening visit, within the first seven days after treatment and after five months follow-up visit
Change from baseline range of motion after treatment and at 5 months
Time Frame: Screening visit, within the first seven days after treatment and after five months follow-up visit

Change from range of movement of ankle and knee during treatment and follow-up period at 5 months. The range of motion of the ankle joint will be measured using a universal goniometer, using the protocol for measuring joint motion described by Felipe Querol.

Measurement instrument: universal goniometer with the protocol to measurement for patients with hemophilia

Screening visit, within the first seven days after treatment and after five months follow-up visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height
Time Frame: Screening visit
Height of patients
Screening visit
Age
Time Frame: Screening visit
Age of patients
Screening visit
Weight
Time Frame: Screening visit
Weight of patients included in the study
Screening visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 12, 2016

Primary Completion (ACTUAL)

September 8, 2017

Study Completion (ACTUAL)

September 26, 2017

Study Registration Dates

First Submitted

June 30, 2016

First Submitted That Met QC Criteria

July 4, 2016

First Posted (ESTIMATE)

July 7, 2016

Study Record Updates

Last Update Posted (ACTUAL)

September 28, 2017

Last Update Submitted That Met QC Criteria

September 26, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Haemophilia

Clinical Trials on Physiotherapy sessions

3
Subscribe